A systematic review highlights the association between immune checkpoint inhibitors and hemophagocytic lymphohistiocytosis (HLH). This research provides insights into the potential risks of HLH in patients receiving these therapies.
immune checkpoint inhibitor associated hemophagocytic lymphohistiocytosis a systematic review
Original title: “Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review.”